Ra Medical Systems Acquires Catheter Precision in Stock-for-Stock Reverse Merger

Medtronic Completes Acquisition of CathWorks

April 20, 2026

Medical Devices

Medtronic plc has completed its acquisition of CathWorks, a privately held medical device company focused on transforming how coronary artery disease is diagnosed and treated. The deal is valued at $585 million, with potential undisclosed earn-out payments, and enhances Medtronic’s interventional cardiology portfolio via the CathWorks FFRangio System.

Stereotaxis Acquires Robocath

April 16, 2026

Medical Devices

Stereotaxis has entered into a definitive agreement to acquire Robocath, a venture-backed developer of robotic technologies for interventional cardiology and neurointerventions. The deal is designed to strengthen Stereotaxis’ position across the full spectrum of endovascular procedures by combining Stereotaxis’ magnetic navigation technology with Robocath’s mechanical multi-device control platform.

RadNet to Acquire iCAD in $103 Million All-Stock Merger

April 21, 2025

Healthcare Services

RadNet, a provider of diagnostic imaging services and digital health solutions, has entered into a definitive merger agreement to acquire iCAD in an all-stock transaction valued at approximately $103 million. The deal is expected to close in the second or third quarter of 2025, subject to iCAD stockholder approval and customary closing conditions.

Abbott Acquires Cardiovascular Systems, Inc.

February 8, 2023

Medical Devices

Abbott entered into a definitive agreement to acquire Cardiovascular Systems, Inc. (CSI), a medical device company focused on atherectomy systems for treating peripheral and coronary artery disease. Under the terms of the deal, CSI stockholders will receive $20 per share, for an expected total equity value of approximately $890 million.

Cirtec Medical Acquires Cardea Catheter Innovations

July 26, 2021

Medical Devices

Cirtec Medical has acquired Cardea Catheter Innovations, a San Jose-based manufacturer of minimally invasive catheter devices and complex delivery systems. Cardea will integrate into Cirtec's NovelCath brand to expand the company's interventional capabilities across structural heart, electrophysiology, and neurovascular markets and will relocate into Cirtec's new San Jose Center of Excellence.

Cirtec Medical Acquires NovelCath

December 17, 2020

Medical Devices

Cirtec Medical Corporation has acquired NovelCath, a vertically integrated manufacturer of catheter delivery systems based in Brooklyn Park, Minnesota. The acquisition expands Cirtec's capabilities in minimally invasive interventional and structural heart device manufacturing and establishes the NovelCath facility as Cirtec's Center of Excellence for Catheters and Delivery Systems.